Latest Singapore News

Elanor Investors Group reported a $24.5 million net loss for the half year to December 2024, grappling with debt covenant breaches and defaults. The group has struck a $125 million recapitalisation agreement with Rockworth Capital Partners to stabilise its balance sheet and pursue growth.

Harvey Norman Holdings Limited reported a robust 6.9% rise in system sales revenue for 1H26, underpinned by strong Australian franchisee performance and overseas expansion. Profit before tax climbed 16.5%, boosted by property revaluations and disciplined cost management.

Activeport Group Ltd reported a 36% revenue decline and a 25% increase in net loss for the half-year ended December 2025, while securing key contracts with Tier 1 telcos and raising $8.8 million in capital.

icetana Limited reports a strong first half of 2026 with recurring revenue up 43%, driven by key partnerships and expanded market reach across APAC and the Middle East.

Percheron Therapeutics reports a 64% reduction in half-year losses to $3.1 million, driven by progress in its licensed immuno-oncology drug HMBD-002 and a strategic pivot away from discontinued assets.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.

Kelsian Group Limited has reported a robust first half for FY26 with double-digit revenue growth and upgraded EBITDA guidance, alongside a strategic $161 million sale of its Tourism Portfolio.

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

Steadfast Group announces the planned retirement of co-founder and CEO Robert Kelly AM, initiating a structured leadership transition with a new CEO expected by August 2026.

The Australian Wealth Advisors Group (AWAG) reported a 46% rise in net profit before tax for the half-year ending December 2025, driven by strong growth in funds under management and strategic joint ventures.

Lendlease reported a statutory loss of $318 million for the half year ended December 2025, reflecting non-cash impairments, while its core Investments, Development and Construction segment delivered solid EBITDA and maintained full-year guidance. The group is focused on capital recycling and balance sheet strengthening ahead of anticipated earnings growth in FY27.

Lendlease Group reported a significant $318 million statutory loss for the half year ended December 2025, driven by impairments and lower transaction earnings. The company plans a $3 billion capital recycling program to reduce gearing and strengthen its balance sheet.